Question 1

What is congenital brain dysgenesis due to glutamine synthetase deficiency?

Accepted Answer

Congenital brain dysgenesis due to glutamine synthetase deficiency is a severe multisystem condition primarily affecting the central nervous system and other organ systems. It is caused by pathogenic variants in the GLUL gene, which encodes the enzyme glutamine synthetase, important for glutamine production. Affected individuals present in the neonatal period with respiratory distress and distinct neurological findings along with metabolic abnormalities. This condition is very rare, affecting fewer than 1 in 1,000,000 people.

Question 2

What are the symptoms of congenital brain dysgenesis due to glutamine synthetase deficiency?

Accepted Answer

The clinical presentation is marked by several characteristic features. Neurologically, there is severe global developmental delay, seizures, and brain atrophy, with structural abnormalities such as hypoplasia of the corpus callosum and decreased cerebrospinal fluid glutamine concentration being consistently observed. Many affected children experience generalized hypotonia, lower limb hyperreflexia, and episodes of apnea, all of which contribute to significant developmental challenges. In addition, respiratory issues such as neonatal respiratory distress and recurrent respiratory infections are common, while various dysmorphic features including low-set ears, short nose, and depressed nasal bridge may be present in a subset of individuals. Not all individuals experience all features, and severity varies considerably.

Question 3

What causes congenital brain dysgenesis due to glutamine synthetase deficiency?

Accepted Answer

This condition is caused by pathogenic variants in the GLUL gene, which encodes glutamine synthetase, a protein vital for maintaining adequate glutamine levels in the brain and body. Its deficiency disrupts normal brain development and metabolic balance, leading to features such as hypoglutaminemia and hyperammonemia. The condition is inherited in an autosomal recessive pattern, meaning that both parents must carry a copy of the altered gene. It is more common when parents share a common ancestor, which increases the likelihood that both carry the same rare variant. Genetic counseling is recommended to help families understand these inheritance implications. Associated genes include GLUL.

Question 4

How is congenital brain dysgenesis due to glutamine synthetase deficiency inherited?

Accepted Answer

congenital brain dysgenesis due to glutamine synthetase deficiency follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How rare is congenital brain dysgenesis due to glutamine synthetase deficiency?

Accepted Answer

congenital brain dysgenesis due to glutamine synthetase deficiency is classified as very rare. The estimated prevalence is approximately <1 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is congenital brain dysgenesis due to glutamine synthetase deficiency diagnosed?

Accepted Answer

Diagnosis is confirmed through molecular genetic testing that identifies pathogenic variants in the GLUL gene. The diagnostic process typically includes a thorough clinical evaluation of characteristic neurological and metabolic features, as well as imaging studies such as brain MRI to assess structural abnormalities like hypoplasia of the corpus callosum. Because many features of this condition can overlap with other disorders, genetic confirmation is essential for an accurate diagnosis.

Question 7

Are there treatments for congenital brain dysgenesis due to glutamine synthetase deficiency?

Accepted Answer

Currently, management focuses on supportive care and symptom management, with treatment tailored to the individual’s needs. There are no treatments specifically approved for this condition, so a multidisciplinary team approach is recommended to address both neurological and systemic symptoms. Supportive strategies may include respiratory support, physical and occupational therapy, and other interventions aimed at improving quality of life. Regular surveillance is an essential part of long-term care to identify potential complications early, and genetic counseling is advised for affected families.

Question 8

Are there clinical trials for congenital brain dysgenesis due to glutamine synthetase deficiency?

Accepted Answer

Yes, there is currently 1 active clinical trial for congenital brain dysgenesis due to glutamine synthetase deficiency registered on ClinicalTrials.gov. Clinical trials test new treatments, procedures, or approaches. Your healthcare provider can help determine if a trial might be appropriate for your situation. Visit the Treatment section of this page for more details.

Question 9

What are the long-term complications of congenital brain dysgenesis due to glutamine synthetase deficiency?

Accepted Answer

Individuals with congenital brain dysgenesis due to glutamine synthetase deficiency often face significant long-term complications. These can include severe developmental delays, ongoing seizures, and respiratory issues. The condition can also lead to challenges in motor function and may require lifelong supportive care and monitoring for potential complications.

Question 10

How does congenital brain dysgenesis due to glutamine synthetase deficiency affect daily life for affected individuals?

Accepted Answer

Daily life for individuals with congenital brain dysgenesis due to glutamine synthetase deficiency can be quite challenging. Many require ongoing therapies such as physical and occupational therapy to help with development and mobility. Additionally, they may need respiratory support and regular medical check-ups to manage their symptoms and monitor their health.

Question 11

What is the prognosis for individuals with congenital brain dysgenesis due to glutamine synthetase deficiency?

Accepted Answer

The prognosis for individuals with congenital brain dysgenesis due to glutamine synthetase deficiency is complex and varies widely. Many individuals face significant neurodevelopmental challenges from an early age, but with specialized care, some may experience periods of stabilization. However, the condition is lifelong, and families should prepare for ongoing support and monitoring.

Question 12

Are there specific specialists recommended for managing congenital brain dysgenesis due to glutamine synthetase deficiency?

Accepted Answer

Yes, managing congenital brain dysgenesis due to glutamine synthetase deficiency typically involves a multidisciplinary team. This may include neurologists, geneticists, and specialists in respiratory care. Working with a team familiar with the condition can help ensure that all aspects of care are addressed effectively.

Organ System	Phenotype Count	Example Features
Brain and nerves	6	Encephalopathy, Seizure, Brain atrophy
Muscles	4	Flexion contracture, Low muscle tone (hypotonia), Generalized hypotonia
Lungs and breathing	3	Recurrent respiratory infections, Neonatal respiratory distress, Apnea
Skin	1	Erythema
Heart and blood vessels	1	Bradycardia
Arms and legs	1	Lower limb hyperreflexia
Blood and immune system	1	Recurrent respiratory infections
Pregnancy and birth	1	Neonatal respiratory distress

Research Type	Count	% of Total
Laboratory research	9	43%
Patient case studies	5	24%
Disease patterns and progression	3	14%
New treatment approaches	2	10%
Research summaries	1	5%
Clinical study results	1	5%

Kisho

congenital brain dysgenesis due to glutamine synthetase deficiency

Overview

Clinical Presentation

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

congenital brain dysgenesis due to glutamine synthetase deficiency

Overview

Clinical Presentation

Medical References

External Resources

OMIM

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is congenital brain dysgenesis due to glutamine synthetase deficiency?

What are the symptoms of congenital brain dysgenesis due to glutamine synthetase deficiency?

What causes congenital brain dysgenesis due to glutamine synthetase deficiency?

How is congenital brain dysgenesis due to glutamine synthetase deficiency inherited?

How rare is congenital brain dysgenesis due to glutamine synthetase deficiency?

How is congenital brain dysgenesis due to glutamine synthetase deficiency diagnosed?

Are there treatments for congenital brain dysgenesis due to glutamine synthetase deficiency?

Are there clinical trials for congenital brain dysgenesis due to glutamine synthetase deficiency?

What are the long-term complications of congenital brain dysgenesis due to glutamine synthetase deficiency?

How does congenital brain dysgenesis due to glutamine synthetase deficiency affect daily life for affected individuals?

What is the prognosis for individuals with congenital brain dysgenesis due to glutamine synthetase deficiency?

Are there specific specialists recommended for managing congenital brain dysgenesis due to glutamine synthetase deficiency?

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications